Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration

European Journal of Preventive Cardiology

Volumn 23, Issue 2, 2016, Pages 194-205

  Willeit, Peter ^a,b   Thompson, Simon G ^a   Agewall, Stefan ^c   Bergström, Göran ^d   Bickel, Horst ^e   Catapano, Alberico L ^f   Chien, Kuo Liong ^g   De Groot, Eric ^h   Empana, Jean Philippe ⁱ   Etgen, Thorleif ^j   Franco, Oscar H ^k   Iglseder, Bernhard ^l   Johnsen, Stein H ^m   Kavousi, Maryam ^k   Lind, Lars ⁿ   Liu, Jing ^o   Mathiesen, Ellisiv B ^m   Norata, Giuseppe D ^f   Olsen, Michael H ^p   Papagianni, Aikaterini ^q   Poppert, Holger ^e   Price, Jackie F ^r   Sacco, Ralph L ^s   Yanez, David N ^t   Zhao, Dong ^o   Schminke, Ulf ^u   Bülbül, Alpaslan ^v   Polak, Joseph F ^w   Sitzer, Matthias ^v,x   Hofman, Albert ^k,y   Grigore, Liliana ^f   Dörr, Marcus ^u   Su, Ta Chen ^g   Ducimetière, Pierre ^z   Xie, Wuxiang ^o   Ronkainen, Kimmo ^aa   Kiechl, Stefan ^b   Rundek, Tatjana ^s   Robertson, Christine ^r   Fagerberg, Björn ^d   Bokemark, Lena ^d   Steinmetz, Helmuth ^v   Ikram, M Arfan ^k   Völzke, Henry ^u   Lin, Hung Ju ^g,ab   Plichart, Matthieu ^i,ac   Tuomainen, Tomi Pekka ^aa   Desvarieux, Moise ^ad,ae   McLachlan, Stela ^r   Schmidt, Caroline ^d   Kauhanen, Jussi ^aa   Willeit, Johann ^b   Lorenz, Matthias W ^v   Sander, Dirk ^e,af   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF MILAN   (Italy)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ INSERM   (France)

^j Klinikum Traunstein   (Germany)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l PARACELSUS MEDICAL UNIVERSITY   (Austria)

^m UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

ⁿ UPPSALA UNIVERSITY   (Sweden)

^o BEIJING INSTITUTE OF HEART   (China)

^p ODENSE UNIVERSITY HOSPITAL   (Denmark)

^q ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^r UNIVERSITY OF EDINBURGH   (United Kingdom)

^s UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF WASHINGTON   (United States)

^u UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^v UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^w TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x Klinikum Herford   (Germany)

^y HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^z UNIVERSITÉ PARIS SACLAY   (France)

^aa UNIVERSITY OF EASTERN FINLAND   (Finland)

^ab NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^ac Paris Descartes University   (France)

^ad University of Eastern Finland ^*  (United States)

^ae EHESP SCHOOL OF PUBLIC HEALTH   (France)

^af Benedictus Krankenhaus Tutzing and Feldafing   (Germany)

more..

Author keywords

atherosclerosis; Inflammation; meta analysis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE COURSE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; PRIORITY JOURNAL; REVIEW; BLOOD; META ANALYSIS;

ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT;

EID: 84953253796     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314560664     Document Type: Review

References (49)

1. Gardin JM, Bartz TM, Polak JF, et al. What do carotid intima-media thickness and plaque add to the prediction of stroke and cardiovascular disease risk in older adults? The cardiovascular health study. J Am Soc Echocardiogr 2014; 27: 998-1005.e2.
2. Den Ruijter HM, Peters SAE, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-analysis. JAMA 2012; 308: 796-803.
3. Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): A meta-analysis of individual participant data. Lancet 2012; 379: 2053-2062.
4. Baldassarre D, Nyyssönen K, Rauramaa R, et al. Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: The IMPROVE study. Eur Heart J 2010; 31: 614-622.
5. Rundek T, Blanton SH, Bartels S, et al. Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke 2013; 44: 2101-2108.
6. Awan Z and Genest J. Inflammation modulation and cardiovascular disease prevention. Eur J Prev Cardiol. 2015; 22: 719-733.
7. The Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367: 1310-1320.
8. Libby P, Ridker PM, Hansson GK,. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
9. Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet 2009; 373: 1175-1182.
10. Sander D, Winbeck K, Klingelhöfer J, et al. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 2004; 109: 1010-1015.
11. Martínez-Vila E, Páramo JA, Beloqui O, et al. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects. Cerebrovasc Dis 2003; 16: 356-362.
12. Ortega E, Gilabert R, Nuñez I, et al. White blood cell count is associated with carotid and femoral atherosclerosis. Atherosclerosis 2012; 221: 275-281.
13. Libby P, Ridker PM, Hansson GK, et al. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
14. Libby P,. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006; 83: 456S-460S.
15. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
16. Syvänen K, Korhonen P, Jaatinen P, et al. High-sensitivity C-reactive protein and ankle brachial index in a Finnish cardiovascular risk population. Int J Angiol 2011; 20: 43-48.
17. Magyar MT, Szikszai Z, Balla J, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003; 34: 58-63.
18. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010; 17: 1-11.
19. Chapman CML, Beilby JP, McQuillan BM, et al. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619-1624.
20. Lorenz MW, Bickel H, Bots ML, et al. Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am Heart J 2010; 159: 730-736.e2.
21. Easton DF, Peto J, Babiker AG,. Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991; 10: 1025-1035.
22. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
23. Winbeck K, Kukla C, Poppert H, et al. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002; 13: 57-63.
24. Xu M, Bi Y, Chen Y, et al. Increased C-reactive protein associates with elevated carotid intima-media thickness in Chinese adults with normal low density lipoprotein cholesterol levels. J Atheroscler Thromb 2013; 20: 575-584.
25. Baldassarre D, De Jong A, Amato M, et al. Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med 2008; 40: 21-44.
26. Temelkova-Kurktschiev T, Koehler C, Henkel E, et al. Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes. Cardiovasc Res 2002; 56: 277-283.
27. Loimaala A, Rontu R, Vuori I, et al. Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006; 188: 363-369.
28. Swirski FK, Nahrendorf M,. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013; 339: 161-166.
29. Lorenz MW, Karbstein P, Markus HS, et al. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: The carotid atherosclerosis progression study. Stroke 2007; 38: 1774-1779.
30. Sabeti S, Exner M, Mlekusch W, et al. Prognostic impact of fibrinogen in carotid atherosclerosis: Nonspecific indicator of inflammation or independent predictor of disease progression? Stroke 2005; 36: 1400-1404.
31. Schillinger M, Exner M, Mlekusch W, et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 2005; 111: 2203-2209.
32. Sander K, Horn CS, Briesenick C, et al. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: The INVADE Study. Stroke 2007; 38: 2881-2886.
33. Van Der Meer IM, De Maat MPM, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The Rotterdam Study. Stroke 2002; 33: 2750-2755.
34. Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001; 104: 63-67.
35. Armstrong C, Abilleira S, Sitzer M, et al. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke 2007; 38: 2895-2899.
36. Paternoster L, Martínez González NA, Lewis S, et al. Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke 2008; 39: 48-54.
37. Sangiorgi G, Roversi S, Biondi Zoccai G, et al. Sex-related differences in carotid plaque features and inflammation. J Vasc Surg 2013; 57: 338-344.
38. Kaptoge S, Di Angelantonio E, et al. Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010; 375: 132-140.
39. Casula M, Tragni E, Zambon A, et al. C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population. Eur J Intern Med 2013; 24: 161-166.
40. Rana JS, Arsenault BJ, Després JP, et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J 2011; 32: 336-344.
41. Elkind MSV, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness: The northern Manhattan study. Stroke 2010; 41: e117-e122.
42. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
43. Markus HS, Labrum R, Bevan S, et al. Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 2006; 37: 2253-2259.
44. Humphries SE, Morgan L,. Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 3: 227-235.
45. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-2586.
46. Desvarieux M, Demmer RT, Jacobs DR, et al. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: The Oral Infections and Vascular Disease Epidemiology study. J Am Heart Assoc 2013; 2: e000254-e000254.
47. Danesh J, Lewington S, et al. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 2005; 294: 1799-1809.
48. Sabater-Lleal M, Huang J, Chasman D, et al. Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013; 128: 1310-1324.
49. Wensley F, Gao P, et al. C Reactive Protein Coronary Heart Disease Genetics Collaboration. Association between C reactive protein and coronary heart disease: Mendelian randomization analysis based on individual participant data. BMJ 2011; 342: d548-d548.